Naproxen Evolan (Naproxen)

Naproxen works by blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for the production of prostaglandins. By lowering prostaglandin levels, it diminishes inflammation, pain signaling, and fever responses at the site of injury or disease.

The specific dosage of Naproxen Evolan is determined by the prescribing healthcare professional based on the individual’s condition, severity, age, and other medical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of naproxen during pregnancy and lactation depends on the trimester and clinical circumstances. It is generally avoided in the third trimester due to potential fetal risks, and caution is advised during early pregnancy and while breastfeeding. Consultation with a healthcare provider is essential before use.

To place an order, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naproxen Evolan shares the core anti‑inflammatory and analgesic properties of other NSAIDs but has a relatively longer half‑life, allowing for less frequent dosing in many cases. Compared with ibuprofen, it may provide more sustained pain control, while the safety profile regarding gastrointestinal and cardiovascular risks is similar across the class.

Naproxen Evolan should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, heat and direct sunlight, and ensure the packaging remains tightly closed until use.

Naproxen Evolan is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. Patients should swallow the tablet whole and not crush or chew it unless directed by a healthcare professional.

The most serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe renal impairment, and rare but severe allergic reactions like anaphylaxis. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Individuals with a known hypersensitivity to naproxen or other NSAIDs, those with active gastrointestinal ulceration or bleeding, patients with severe heart failure, recent myocardial infarction, or uncontrolled hypertension should avoid Naproxen Evolan. Pregnant women in the third trimester and patients with significant renal or hepatic impairment should also refrain unless specifically advised by a physician.